In a challenging market environment, NAYA stock has touched a 52-week low, with shares plummeting to $0.35. According to InvestingPro data, the company's financial health score is rated as WEAK, with ...

Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates.

Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.

This study investigated the long-term prognosis and clinical course of patients who survived for more than 5 years after hepatocellular carcinoma (HCC) diagnosis.This retrospective cohort study used ...

Announcing a new publication for Acta Materia Medica journal. Icaritin (ICA) is a prenylflavonoid natural product extracted from plants of the Epimedium genus.

Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...

A newly developed nomogram predicts preoperative microvascular invasion in patients with HCC, improving surgical planning and outcomes.

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

Hosted by Terry Gross, the show features intimate conversations with today's biggest luminaries. Subscribe to Fresh Air Plus! You'll enjoy bonus episodes and sponsor-free listening - all while you ...

Most of the rest of this information is about hepatocellular carcinoma and will be referred to as liver cancer. About 10% to 20% of liver cancers start in the cells that line the small bile ducts ...